Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1040
Peer-review started: August 30, 2022
First decision: November 25, 2022
Revised: December 7, 2022
Accepted: January 20, 2023
Article in press: January 20, 2023
Published online: February 16, 2023
Processing time: 167 Days and 23.3 Hours
Radiotherapy is a common treatment method for malignant thoracic tumors. However, it is associated with complications, such as radiation pneumonitis that is mainly caused by the radiation-induced damage to the pulmonary vascular endothelial cells and parenchymal cells. It can develop into chronic inflammation and pulmonary fibrosis and may reduce the effectiveness of the treatment and impact the quality of life of cancer patients.
Early prevention of radiation pneumonitis is very important. Clinical continuous comprehensive analysis of associated risk factors and the formulation of targeted preventative methods may reduce the incidence of this complication.
To carry out multiple regression analysis on the influencing factors of radiation pneumonitis.
Records of patients receiving chest radiotherapy between January 2018 to February 2021 were collected and divided into two groups according to whether radiation pneumonitis was diagnosed. Multiple regression analysis was performed on age, tumor type, chemotherapy history, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), DLCO, FEV1/FVC ratio, planned target area (PTV), mean lung dose (MLD), total number of radiation fields, percentage of lung tissue in total lung volume (vdose), probability of normal tissue complications (NTCP), and other factors.
The proportions of patients with an age ≥ 60 years, lung cancer diagnosis, and a history of chemotherapy in the study group were higher than those in the control group (P < 0.05); FEV1, DLCO, and FEV1/FVC ratio in the study group were lower than those in the control group (P < 0.05), while PTV, MLD, total field number, vdose, and NTCP were higher than those in the control group (P < 0.05). Logistic regression analysis showed that age, lung cancer diagnosis, chemotherapy history, FEV1, FEV1/FVC ratio, PTV, MLD, total number of radiation fields, vdose, and NTCP were risk factors for radiation pneumonitis.
The risk factors for radiation pneumonitis include patient age, lung cancer diagnosis, history of chemotherapy, lung function, and radiotherapy parameters.
A comprehensive evaluation and examination should be carried out before beginning the radiotherapy treatment. Clinicians should fully consider all the influencing factors based on the individual situation of each patient, to design a scientific and reasonable radiotherapy plan.